Research ethics and who sets the agenda
Who funds autism research, who sits on the committees that set its priorities, and who owns the data it collects: the 2026 overhaul of the US federal committee, the independent committee formed in response, and the Spectrum 10K case.
Who pays for autism research, who gets to decide what it studies, and who owns the information it collects.
Who sets the federal research agenda Established
The main body that sets the US federal agenda is the Interagency Autism Coordinating Committee (IACC). It is a federal advisory committee that coordinates federal autism efforts and advises the Secretary of Health and Human Services, and it includes both federal officials and public members.1 Congress first established it in the Children's Health Act of 2000 and chartered it as a federal advisory committee in the Combating Autism Act of 2006; it has been reauthorized several times since, most recently in the Autism CARES Act of 2024, which runs to September 2029.2 The law requires it to write a strategic plan for autism research and to report to Congress each year on scientific advances.3
On 28 January 2026, HHS announced the appointment of 21 new members to the IACC.4 Alison Singer, the president of the Autism Science Foundation, a former IACC member who now sits on the new independent committee, called the change "a complete and unprecedented overhaul, with no continuity from prior committees", and said the new panel "disproportionately represents a tiny subset of families who believe vaccines cause autism".3 The chair at the time, Sylvia Fogel, described the same panel in different terms: 20 public members, eight of whom support children with "profound autism", another four who support children with a range of support needs, both on and off the spectrum, and three autistic members, two of them non-speaking with high support needs. One member, she said, had stepped down, and the panel had "fewer researchers" than earlier committees.5
The committee writes the plan that directs federal autism research money. In August 2026 it adopted a new strategic plan that de-emphasized genetics and called for more research on environmental factors and the causes of regression.6 Weeks later, on 18 September 2026, the HHS Secretary replaced Fogel as chair, naming John Gaitanis, the director of the National Institute of Child Health and Human Development; Fogel stayed on as a public member.6
Where that money goes, and where autistic people and families would rather it go, is covered in Self-advocacy.
In the United States, one committee sets the plan for autism research. It is called the Interagency Autism Coordinating Committee, or IACC. It advises the government on autism. It includes government officials and members of the public.1 Congress started it in 2000. It became an official committee in 2006. Later laws renewed it, most recently in 2024.2 The law says the committee must write a plan for autism research and tell Congress what scientists have learned.3
On 28 January 2026, the government announced 21 new members for the committee.4 Alison Singer, who leads the Autism Science Foundation, called this a huge change, with nobody kept from before. She said the new group mostly speaks for families who believe vaccines cause autism.3 The chair at the time, Sylvia Fogel, described the group in another way. She said it has 20 public members. Eight of them have children with "profound autism". Four more have children with other support needs. Three members are autistic, and two of them do not speak.5
This committee writes the plan that says where research money should go. In August 2026 it adopted a new plan. The plan focused less on genes, and more on the world around us and on why some children lose skills.6 A few weeks later, on 18 September 2026, the government chose a new chair, John Gaitanis. Fogel stayed on the committee.6
Where the money goes, and what autistic people would rather it study, is covered in Self-advocacy.
A record of official announcements, a press release and the committee's own documents. These are dated claims about what bodies said and did, not research findings.
An announcement, a strategic plan or a committee appointment records what a body said or did, on a date. It is a document, not a finding, and it does not settle whether the science behind it holds.
These are facts about what government bodies said and did. They are not research findings.
An announcement or a plan shows what a group said or did on a date. It is a record. It does not prove the science is right.
The Independent Autism Coordinating Committee Established
On 3 March 2026, autism research and advocacy leaders announced the formation of the Independent Autism Coordinating Committee (I-ACC), a non-governmental body set up to coordinate work among non-governmental autism research funders.3 It was a response to the overhaul of the federal committee; Disability Scoop reported it as "a direct rebuke of the reshaped government panel".7 Its first meeting was held at the National Press Club in Washington, DC, on 19 March 2026.3
The I-ACC is modeled on the federal committee. It writes its own strategic plan for autism research, reports each year on advances, and meets on the same schedule as the federal IACC so that it can respond to recommendations it considers unsupported by the science.3 Its members include two former directors of the National Institute of Mental Health, Joshua Gordon and Tom Insel, who chaired the federal IACC in earlier terms, along with researchers, clinicians and advocates; the Autism Science Foundation serves as its secretariat.3,7
The two committees disagree in public. In 2026 the I-ACC submitted formal comments on the federal IACC's draft strategic plan. The comments opened by welcoming much of the draft, then criticized it for not adequately building on earlier IACC work and for giving "disproportionate attention to biological and therapeutic hypotheses with very different levels of evidentiary support".8
On 3 March 2026, a group of autism researchers and advocates announced a new committee. It is called the Independent Autism Coordinating Committee, or I-ACC. It is not part of the government. It was set up to link up the groups that pay for autism research.3 It was a reply to the changes in the government committee. A news site, Disability Scoop, called it "a direct rebuke" of the new government panel.7 Its first meeting was on 19 March 2026, in Washington, DC.3
The I-ACC works like the government committee. It writes its own research plan. It reports each year on what scientists learn. It meets at the same times, so it can answer the government panel quickly.3 Its members include two former leaders of a big government health institute, Joshua Gordon and Tom Insel. The Autism Science Foundation does its office work.3,7
The two committees disagree in public. In 2026 the I-ACC sent comments on the government's draft plan. It praised parts of the plan. Then it said the plan ignored earlier work and leaned on ideas with weak evidence.8
Described from the committee's own announcements and from news reporting. Facts about an organization, not research findings.
The office that handles the day-to-day administration of a committee or organization.
These are facts about an organization. They come from its own announcements and from news reports.
The office that does the day-to-day work for a committee.
Who takes part, and consent Emerging
Autism research has long drawn its samples from a narrow slice of the population. Tafolla and Lord write that the field lacks representation of "racially diverse individuals who are multilingual from low-income households", which calls the generalizability of its findings into question; they describe engaging and retaining 94 Spanish and English speaking Latinx families from low-income households, and set out strategies for including groups that research often misses.9
Consent is the other half of the same problem. Khatiwada and colleagues argue that the US "reasonable person" standard for informed consent, which asks what an "average" person would want to know, "systematically fails to meet the informational needs of (many) people from minoritized populations", including many autistic people, and they argue for an individualized standard instead.10
Participatory practice is written into guidance. The AASPIRE practice-based guidelines, from a US academic and community partnership, ask teams that include autistic adults as co-researchers to define clear roles, share power with them, pay them fairly and avoid tokenizing them, and they ask study teams to make the consent process as accessible as possible.11 How far such involvement changes the research itself is covered in Self-advocacy.
Autism studies often look at only a small slice of people. Tafolla and Lord write that many groups are left out. Some people are not White. Some speak more than one language. Some have less money. This makes it hard to know if the results fit everyone.9 They describe how they found and kept 94 Latinx families who speak Spanish and English and have low incomes.9
Agreeing to join a study is the other problem. Khatiwada and colleagues say the usual test for consent asks what an "average" person would want to know. They say this leaves out many people, including many autistic people. They say each person should get the facts that matter to them.10
Some guides now say how to include autistic people well. The AASPIRE guidelines ask research teams to give autistic co-researchers clear roles. They ask teams to share power, to pay them, and not to include them just for show. They also ask teams to make consent easy to understand.11 Whether this changes the research itself is covered in Self-advocacy.
A methods paper and a bioethics analysis, both arguments rather than studies, and practice guidance from one partnership. No systematic review or replicated finding.
Including someone for appearance, without giving them real influence.
These come from a few papers and one group's advice. They are not large or repeated studies.
Including someone just for show, without giving them real power.
Genetic data, privacy and ownership Emerging
Genetic and behavioral data raise a problem that individual consent does not solve. The bioethicists Chapman, Quinn and colleagues argue that genomic and other data-centric research can harm whole groups, not only the people who take part, because findings can be turned against everyone who shares a trait, and they ask whether US research rules need revision to protect group interests.12 A review co-produced with autistic and other stakeholders argues that autistic people's perspectives must be central to discussions about the ethics and technology of sharing autism data, and points to emerging models such as federated data sharing and community-run registries.13
What contributors themselves say is mixed. In a study of 71 people who gave samples to the Australian Autism Biobank, 18 autistic adolescents and young adults, 46 of their parents and seven siblings, contributors said they trusted scientists to keep their information safe and wanted to know how it would be used later; some said that knowing why some people are autistic could help them make choices about having children in future.14 In an international survey of 173 autistic adults, beliefs about genetic testing varied widely; the 19 who had already had testing were much more positive about it than those who had not.15 A 2026 survey in Sweden, of 871 parents and 213 autistic people, found generally positive views of genetic research alongside concerns about the misuse of genetic information, including for eugenics.16 A scoping review found the evidence on genetic testing and stigma thin; of its 25 articles, 22 studied parents and only 3 included autistic adults.17 A separate study of 20 parents of nonverbal or minimally verbal autistic children found them supportive of autism research, including some genomic research, provided it was designed to support autistic people and was ethical and transparent; the parents said they felt excluded from the autistic and autism communities, and that the dominant voices there did not represent them or their children.18
Your genes are data about you. They are also data about people who share them. Two experts on research ethics, Chapman and her colleagues, study this. They say gene research can harm whole groups. That can include people who are not in the study. The findings can be used against everyone with a certain trait. They ask if US rules should change to protect groups.12 A review written with autistic people says autistic people should help decide how their data is shared. It points to new ways, such as sharing data without moving it.13
What people themselves think is mixed. In one study, 71 people gave samples to an autism biobank in Australia. They trusted scientists to keep their data safe. They wanted to know how it would be used later.14 Some said that knowing why some people are autistic could help them decide about having children.14 In a survey of 173 autistic adults, views about gene testing were very different. The 19 who had been tested felt much more positive about it.15 A survey in Sweden found mostly positive views, along with worry about misuse, such as for eugenics.16 A review found little evidence on gene testing and stigma. Of its 25 studies, 22 asked parents, and only 3 included autistic adults.17 In one study of 20 parents of children who speak little or not at all, parents backed some gene research. They backed it if it helped autistic people and was open and fair. Some felt left out of the autistic community. They said its main voices did not speak for them.18
Two bioethics analyses, two surveys and a scoping review, all small or mixed, and no replicated finding.
Two opinion papers, two surveys and one review. All are small or mixed, and none has been repeated.
Spectrum 10K Established
Spectrum 10K was billed as the largest study of autism in the UK. It launched in August 2021, led by the University of Cambridge with the Wellcome Sanger Institute and the University of California, Los Angeles, and funded by the Wellcome Trust; it aimed to collect genomes from 10,000 autistic people and, where possible, their families.19,20
The team paused recruitment less than three weeks after launch, after an outcry from autism charities, advocacy organizations and autistic community members. Critics said the organizers had not been clear about how the project would benefit autistic people, and that there were problems with how the researchers planned to handle consent and DNA samples.21 A "Stop Spectrum 10K" petition alleged that the organizers had "direct links to organisations that advocate for cures and eugenics" and that DNA samples could be used for prenatal screening; the UK National Autistic Society said the project raised "serious concerns and questions, particularly about the nature of the consent, the collection of DNA samples and how this could be used in the future", and a coalition called Boycott Spectrum 10K said the project had not been clear about how the research would help autistic people.21 The lead investigator apologized "unreservedly" and paused the study.21 The UK Health Research Authority, which oversees research ethics committees, upheld the study's original ethics approval but asked the team to revise its consent documents, and listed, among the concerns raised with it, a lack of safeguards over how participants' genetic data might be shared and used. The team told the HRA that data would not be shared to develop a prenatal test for autism or a cure.19 By then, 4,388 people had registered, including 99 caregivers consenting for autistic adults who could not consent for themselves.19
The team then ran a consultation to rework the study, co-led by an autistic researcher, Karen Leneh Buckle, and a facilitation agency. By the team's account it drew feedback from more than 500 autistic people and their families, and the team released its report in January 2025.21 The project was closed on 30 January 2025; its leadership said data collection was no longer necessary to meet the study's goals.21 The episode left the question of how early ethics and public engagement should enter a study's design; the Oxford ethicist Ilina Singh said such work "should be in research design from the very start".19
In the studies above, parents of nonverbal or minimally verbal autistic children backed autism research, including some genomic research, as long as it was designed to support autistic people and was ethical and transparent, and autistic adults' views varied widely rather than being uniformly opposed.18,15
Spectrum 10K was meant to be the biggest autism study in the UK. It began in August 2021. It was run by the University of Cambridge with two other centers, and paid for by the Wellcome Trust. It planned to collect DNA from 10,000 autistic people and their families.19,20
Less than three weeks later, the team stopped signing people up. Autism charities, advocacy groups and autistic people had raised concerns.21 Critics said the team was not clear about how the study would help autistic people. They said there were problems with consent and with DNA samples.21 A petition said the researchers had links to groups that want to "cure" autism. It said DNA could be used for screening before birth. The National Autistic Society said the project raised "serious concerns and questions" about consent and DNA. The lead researcher said sorry and paused the study.21 A UK ethics body said the study could go on, but asked for new consent forms. It said people had raised concerns about how the data would be kept safe. The team promised not to use the data to make a test before birth or a cure.19 By then, 4,388 people had joined. That included 99 caregivers who agreed for adults who could not agree for themselves.19
The team then asked autistic people how to fix the study. An autistic researcher helped lead this work. The team said more than 500 people took part. It released its report in January 2025.21 The project closed on 30 January 2025.21 Later, a professor of ethics, Ilina Singh, said ethics work "should be in research design from the very start".19
A sequence of dated events, from the study team, the UK Health Research Authority and news reporting. Documents, not research findings.
These are dated facts, from the study team, a UK ethics body and news reports.
In the community Community
Many autistic writers treat who controls research as a question of power, as well as of method. In the Routledge International Handbook of Critical Autism Studies, Sara Ryan and Damian Milton write that the campaign against Spectrum 10K "led to the suspension of the study within weeks" and call it evidence of "shifting power within the autism research arena".c1 Jules Edwards and Meghan Ashburn write in I Will Die On This Hill: "Most research about autistic people isn't actually performed by autistic people. Consequently, most research doesn't focus on topics that the autistic community feels are important."c2
Writers also connect genetic research to a wider fear. They ask for research that answers to the people it studies, and for a say in how their data is used; the worries about where genetic findings could lead, including toward selective screening, are set out in Embryo screening, polygenic scores and eugenics fears. The community idea behind the demand, "nothing about us without us", is covered in Self-advocacy.
Many autistic writers say that who controls research is about power. Sara Ryan and Damian Milton write in a book on autism studies. The campaign against Spectrum 10K "led to the suspension of the study within weeks", they say. They call it a sign of "shifting power" in autism research.c1
Jules Edwards and Meghan Ashburn write in a book. They say: "Most research about autistic people isn't actually performed by autistic people." So it misses what they want.c2
Writers also worry about where gene research could lead. One fear is screening before birth. That worry is covered in Embryo screening, polygenic scores and eugenics fears. The idea behind it, "nothing about us without us", is covered in Self-advocacy.
How autistic writers describe who should set the research agenda. Not a research finding.
How autistic writers talk about who should decide research. This is not a research finding.
Sources
Research
- 1Interagency Autism Coordinating Committee. IACC Overview. US Department of Health and Human Services. https://iacc.hhs.gov/about-iacc/overview/
- 2Interagency Autism Coordinating Committee. IACC Legislation. US Department of Health and Human Services. https://iacc.hhs.gov/about-iacc/legislation/
- 3Autism Science Foundation. Autism Research Leaders Announce Independent Autism Coordinating Committee (I-ACC). Autism Science Foundation, 2026. https://autismsciencefoundation.org/press_releases/i-acc-announcement/
- 4US Department of Health and Human Services. Secretary Kennedy Appoints New Interagency Autism Coordinating Committee to Advance Fight Against Autism. HHS Press Office, 2026. https://www.hhs.gov/press-room/hhs-kennedy-appoints-new-interagency-autism-coordinating-committee.html
- 5Fogel S, interviewed by Huggett B. Sylvia Fogel, reshaping U.S. autism research strategy (transcript). The Transmitter, 2026. https://www.thetransmitter.org/wp-content/uploads/2026/09/TT-Fogel-IACC-autism-policy-transcript.pdf
- 6Huggett B. Sylvia Fogel, reshaping U.S. autism research strategy. The Transmitter, 2026. https://www.thetransmitter.org/spectrum/sylvia-fogel-reshaping-u-s-autism-research-strategy/
- 7Diament M. Troubled By RFK Jr.'s Overhaul Of Federal Autism Panel, Experts Launch Their Own. Disability Scoop, 2026. https://www.disabilityscoop.com/2026/03/04/troubled-by-rfk-jr-s-overhaul-of-federal-autism-panel-experts-launch-their-own/31886/
- 8Independent Autism Coordinating Committee. Public comment in response to the federal IACC draft strategic plan. I-ACC, 2026. https://www.i-accautism.org/_files/ugd/df2b91_26de5587be2d42e9830018b5b7e8139b.pdf
- 9Tafolla M, Lord C. Expanding the autism evidence base: Strategies to increase participant representation. Autism, 2026. https://doi.org/10.1177/13623613251393505
- 10Khatiwada M, Howard D, Krempley T, et al. Reasonable to Whom? Rethinking Informed Consent Disclosures in Light of the Research Related Concerns of the Autistic Community. The American Journal of Bioethics, 2026. https://doi.org/10.1080/15265161.2026.2632012
- 11Nicolaidis C, Raymaker D, Kapp SK, et al. The AASPIRE practice-based guidelines for the inclusion of autistic adults in research as co-researchers and study participants. Autism, 2019. https://doi.org/10.1177/1362361319830523
- 12Chapman CR, Quinn GP, Natri HM, et al. Consideration and Disclosure of Group Risks in Genomics and Other Data-Centric Research: Does the Common Rule Need Revision? The American Journal of Bioethics, 2025. https://doi.org/10.1080/15265161.2023.2276161
- 13Lautarescu A, Trost B, Kushki A, et al. Autism data sharing: Benefits, challenges, and recommendations. PLOS Digital Health, 2026. https://doi.org/10.1371/journal.pdig.0001249
- 14Lilley R, Rapaport H, Poulsen R, et al. Contributing to an autism biobank: Diverse perspectives from autistic participants, family members and researchers. Autism, 2024. https://doi.org/10.1177/13623613231203938
- 15Gallion T, Williams ZJ, Niarchou M, et al. Attitudes of autistic adults toward genetic testing for autism. Journal of Genetic Counseling, 2025. https://doi.org/10.1002/jgc4.1918
- 16Fajutrao Falk S, Hellquist A, Tammimies K. A Survey-Based Study Investigating Opinions on Genetic Research Among Swedish Autistic Individuals and Parents of Autistic Children. Autism, 2026. https://doi.org/10.1177/13623613261458410
- 17Molloy CJ, Miles A, Christoff C, et al. Does genetic testing impact stigma in autism: A scoping review. Journal of Community Genetics, 2026. https://doi.org/10.1007/s12687-025-00854-8
- 18Asbury K, Toseeb U, Barrow N, et al. What do parents of nonverbal and minimally verbal autistic children think about genomic autism research? Autism, 2024. https://doi.org/10.1177/13623613231213431
- 19Dattaro L. Spectrum 10K gets green light from ethics agency. The Transmitter, 2022. https://www.thetransmitter.org/spectrum/spectrum-10k-gets-green-light-from-ethics-agency/
- 20Spectrum 10K. About Spectrum 10K. University of Cambridge, 2021. https://web.archive.org/web/20210824071927/https://spectrum10k.org/
- 21O'Grady C. Spectrum 10K consultation report delayed. The Transmitter, 2024. https://www.thetransmitter.org/spectrum/spectrum-10k-consultation-report-delayed/
Community sources
- c1Milton D, Ryan S, eds. The Routledge International Handbook of Critical Autism Studies. Routledge, 2022. Chapter "Critical autism studies: An introduction" (Sara Ryan and Damian Milton).
- c2Ashburn M, Edwards J, Onaiwu M. I Will Die On This Hill: Autistic Adults, Autism Parents, and the Children Who Deserve a Better World. Jessica Kingsley Publishers, 2023. Chapter 15, "Finding My Niche", section "Jules and Meghan".